The Effect of Acute Ischemia on ET-1 and Its Receptors in Patients with Underlying Chronic Ischemia of the Lower Limb

Abstract

Elevated plasma and tissue endothelin (ET)-1 levels in patients with critical limb ischemia (CLI) has been described. Here the effect of a period of acute ischemia and subsequent reperfusion on plasma ET-1 and tissue ET-1/ET receptors in skeletal muscle biopsies from CLI patients undergoing femoro-distal bypass surgery was studied. Peripheral and “local” blood and muscle biopsies were obtained from patients undergoing femoro-distal bypass surgery, at the start of the procedure (control), after a period of vascular clamping (ischemia), and after clamp release (reperfusion). Plasma ET-1 was determined by enzyme-linked immunosorbent assay. Tissue ET-1 was assessed by counting ET-1 immunostaining cells per unit area, and ET_A/ET_B receptors were identified on sections by in vitro autoradiography in which binding was quantitatively assessed by densitometry. There was no significant effect of ischemia or reperfusion on plasma ET-1 levels or on ET_A/ET_B receptor binding. However, tissue ET-1 increased during both acute ischemia and reperfusion (P < 0.05). A high proportion of positive ET-1 immunostaining was associated with microvessels and also exhibited a similar distribution to macrophages. Previously, it has been shown that both plasma ET-1 and tissue ET-1/ET receptors are increased in CLI patients compared with atherosclerotic controls. Also, increased muscle ET-1 levels have been described in acute ischemia caused by tourniquet application in nonischemic patients undergoing total knee replacement. In CLI patients, in whom ET-1 is already upregulated, this further increase may exacerbate existing pathologic processes and contribute to ischemia-reperfusion injury. ET-1 antagonists may therefore be useful adjuncts in CLI and other surgical procedures in which ischemia-reperfusion damage occurs.

Get full access to this article

View all access options for this article.

References

Mangiafico RA, Malatino LS, Santonocito M, Sarnataro F, Dell’Arte S, Messina R, Santangelo B. Plasma ET-1 levels in patients with peripheral arterial occlusive disease at different Fontaine’s stages. Panminerva Med 41:22–26, 1999.

Tsui JC, Baker DM, Biecker E, Shaw S, Dashwood MR. Potential role of endothelin-1 in ischaemia-induced angiogenesis in critical limb ischaemia. Br J Surg 89:741–747, 2002.

Schroeder TV. The TASC supplement—international recommendations for management of peripheral arterial disease. Eur J Vasc Endovasc Surg 19:563, 2000.

Hillier C, Sayers RD, Watt PA, Naylor R, Bell PR, Thurston H. Altered small artery morphology and reactivity in critical limb ischaemia. Clin Sci (Lond) 96:155–163, 1999.

Coats P. Myogenic, mechanical and structural characteristics of resistance arterioles from healthy and ischemic subjects. Clin Sci (Lond) 105:683–689, 2003.

Dashwood MR, Timm M, Muddle JR, Ong AC, Tippins JR, Parker R, McManus D, Murday AJ, Madden BP, Kaski JC. Regional variations in endothelin-1 and its receptor subtypes in human coronary vasculature: pathophysiological implications in coronary disease. Endothelium 6: 61–70, 1998.

Tsui JC, Baker DM, Biecker E, Shaw S, Dashwood MR. Altered endothelin-1 levels in acute lower limb ischaemia and reperfusion. Angiology 55:533–539; 2004.

Remuzzi G, Begnini A. Endothelins in the control of cardiovascular and renal function. Lancet 342:589–593, 1993.

Yasuda M, Kohno M, Tahara A, Itagane H, Toda I, Akioka K, Teragaki M, Oku H, Takeuchi K, Takeda T. Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J 119:801–806, 1990.

10.

Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke 23: 1014–1016, 1992.

11.

Soong CV, Barros B’Sa AA. Lower limb oedema following distal arterial bypass grafting. Eur J Vasc Endovasc Surg 16:465–471, 1998.

12.

Tsui JC, Baker DM, Biecker E, Shaw S, Dashwood MR. Evidence for the involvement of endothelin-1 but not urotensin II in chronic lower limb ischaemia in man. Eur J Vasc Endovasc Surg 25:443–450, 2003.